Contraline Stock

Contraline is developing the first long-lasting, reversible contraceptive for men

About Contraline Stock

Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive.

Funding History

July 2014	$0
June 2016	$680K
March 2017	$2.3M
July 2018	$0
September 2018	$0

Management

COO

Nicole E. Hastings

Co-Founder & CEO

Kevin Eisenfrats

Press

The 2018 30 Under 30 In Healthcare

Forbes - Nov, 14 2017

Meet the company that’s looking to make non-surgical male birth control a reality

TechCrunch - Apr, 5 2017

Other Companies

Learn More

Bayer

Multinational pharmaceutical and life sciences company

$3.0BTotal Funding

Learn More

Curology

Curology provides actual prescription skincare – customized for your skin and delivered to your door.

$18.8MTotal Funding

Learn More

Newlight Technologies

Founded out of Princeton University and Northwestern University in 2003, Newlight has developed, patented, and commercialized the world's

$39.0MTotal Funding

Learn More

Recursion Pharmaceuticals

Artificial intelligence to discover treatments

$206MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Contraline or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.